Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines

Nature Communications

Volumn 5, Issue , 2014, Pages

  Banchereau, Romain ^a   Baldwin, Nicole ^a   Cepika, Alma Martina ^a   Athale, Shruti ^a   Xue, Yaming ^a   Yu, Chun I ^a   Metang, Patrick ^a   Cheruku, Abhilasha ^a   Berthier, Isabelle ^a   Gayet, Ingrid ^a   Wang, Yuanyuan ^a   Ohouo, Marina ^a   Snipes, LuAnn ^a   Xu, Hui ^a   Obermoser, Gerlinde ^a   Blankenship, Derek ^a   Oh, Sangkon ^a   Ramilo, Octavio ^b   Chaussabel, Damien ^c,d   Banchereau, Jacques ^a,e   Palucka, Karolina ^a,e   Pascual, Virginia ^a   more..

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^e JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; APC PROTEIN; CD1C ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLUENZA VACCINE; INTERLEUKIN 4; PNEUMOCOCCUS VACCINE; VACCINE; WART VIRUS VACCINE; BLOOD DENDRITIC CELL ANTIGEN 3, HUMAN; CD1 ANTIGEN; CD1C PROTEIN, HUMAN; CYTOKINE; GLYCOPROTEIN; MEMBRANE ANTIGEN; TRANSCRIPTOME;

BACTERIUM; BLOOD; CELLS AND CELL COMPONENTS; INFECTIVITY; INFLUENZA; PATHOGEN; VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; CELL MATURATION; DENDRITIC CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFLUENZA A VIRUS (H1N1); INNATE IMMUNITY; MONOCYTE; NONHUMAN; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; TRANSCRIPTOMICS; VACCINATION; ALGORITHM; ANIMAL; CHEMISTRY; CLUSTER ANALYSIS; CYTOLOGY; DOG; GENE EXPRESSION PROFILING; MDCK CELL LINE; METABOLISM; MICROBIOLOGY; PRINCIPAL COMPONENT ANALYSIS;

SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS;

ALGORITHMS; ANIMALS; ANTIGENS, CD1; ANTIGENS, SURFACE; CLUSTER ANALYSIS; CYTOKINES; DENDRITIC CELLS; DOGS; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERLEUKIN-4; MADIN DARBY CANINE KIDNEY CELLS; MONOCYTES; PRINCIPAL COMPONENT ANALYSIS; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; VACCINES;

EID: 84922788803     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6283     Document Type: Article

References (59)

1. Pulendran, B. & Ahmed, R. Immunological mechanisms of vaccination. Nat. Immunol. 12, 509-517 (2011).
2. Jung, S. et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17, 211-220 (2002).
3. Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
4. Henri, S. et al. Disentangling the complexity of the skin dendritic cell network. Immunol. Cell Biol. 88, 366-375 (2010).
5. Klechevsky, E. et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29, 497-510 (2008).
6. Duluc, D. et al. Functional diversity of human vaginal APC subsets in directing T-cell responses. Mucosal Immunol. 6, 626-638 (2012).
7. Bogunovic, M. et al. Origin of the lamina propria dendritic cell network. Immunity 31, 513-525 (2009).
8. Kinnebrew, M. A. & Pamer, E. G. Innate immune signaling in defense against intestinal microbes. Immunol. Rev. 245, 113-131 (2012).
9. Chu, C. C. et al. Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J. Exp. Med. 209, 935-945 (2012).
10. Ginhoux, F. et al. The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 206, 3115-3130 (2009).
11. Colonna, M., Trinchieri, G. & Liu, Y. J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219-1226 (2004).
12. Reizis, B., Bunin, A., Ghosh, H. S., Lewis, K. L. & Sisirak, V. Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29, 163-183 (2011).
13. Bendriss-Vermare, N. et al. Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J. Clin. Invest. 107, 835-844 (2001).
14. Segura, E. et al. Human inflammatory dendritic cells induce th17 cell differentiation. Immunity 38, 336-348 (2013).
15. Cheong, C. et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 143, 416-429 (2010).
16. Collin, M., McGovern, N. & Haniffa, M. Human dendritic cell subsets. Immunology 140, 22-30 (2013).
17. Kawai, T. & Akira, S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650 (2011).
18. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010).
19. Elinav, E., Strowig, T., Henao-Mejia, J. & Flavell, R. A. Regulation of the antimicrobial response by NLR proteins. Immunity 34, 665-679 (2011).
20. Geijtenbeek, T. B. & Gringhuis, S. I. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9, 465-479 (2009).
21. Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S. & Reis e Sousa, C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531 (2004).
22. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 (2004).
23. Navarini, A. A. et al. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc. Natl Acad. Sci. USA 103, 15535-15539 (2006).
24. Guarda, G. et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34, 213-223 (2011).
25. Jamieson, A. M., Yu, S., Annicelli, C. H. & Medzhitov, R. Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe 7, 103-114 (2010).
26. Barker, B. R., Taxman, D. J. & Ting, J. P. Cross-regulation between the IL-1beta/IL-18 processing inflammasome and other inflammatory cytokines. Curr. Opin. Immunol. 23, 591-597 (2011).
27. Chuang, H. Y., Hofree, M. & Ideker, T. A decade of systems biology. Annu. Rev. Cell Dev. Biol. 26, 721-744 (2010).
28. Vidal, M., Cusick, M. E. & Barabasi, A. L. Interactome networks and human disease. Cell 144, 986-998 (2011).
29. Ramilo, O. et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109, 2066-2077 (2007).
30. Berry, M. P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973-977 (2010).
31. Banchereau, R. et al. Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections. PLoS ONE 7, e34390 (2012).
32. Pascual, V., Allantaz, F., Arce, E., Punaro, M. & Banchereau, J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med. 201, 1479-1486 (2005).
33. Allantaz, F. et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J. Exp. Med. 204, 2131-2144 (2007).
34. Huang, Y. et al. Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection. PLoS Genet. 7, e1002234 (2011).
35. Chaussabel, D. et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29, 150-164 (2008).
36. Cancer Genome Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
37. Cancer Genome Atlas Research, N. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
38. Querec, T. D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116-125 (2009).
39. Gaucher, D. et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119-3131 (2008).
40. Obermoser, G. et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 38, 831-844 (2013).
41. Amit, I. et al. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326, 257-263 (2009).
42. Lee, M. N. et al. Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach. Nat. Immunol. 14, 179-185 (2013).
43. Cavalieri, D. et al. DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cells. Immunome Res. 6, 10 (2010).
44. Miller, J. C. et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13, 888-899 (2012).
45. Heng, T. S. & Painter, M. W. Immunological Genome Project Consortium. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9, 1091-1094 (2008).
46. Chaussabel, D. & Baldwin, N. Democratizing systems immunology with modular transcriptional repertoire analyses. Nat. Rev. Immunol. 14, 271-280 (2014).
47. Pulendran, B., Li, S. & Nakaya, H. I. Systems vaccinology. Immunity 33, 516-529 (2010).
48. Oberg, A. L., Kennedy, R. B., Li, P., Ovsyannikova, I. G. & Poland, G. A. Systems biology approaches to new vaccine development. Curr. Opin. Immunol. 23, 436-443 (2011).
49. Germain, R. N. Vaccines and the future of human immunology. Immunity 33, 441-450 (2010).
50. Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15, 195-204 (2014).
51. Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118 (1994).
52. Blanco, P., Palucka, A. K., Gill, M., Pascual, V. & Banchereau, J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294, 1540-1543 (2001).
53. Nakaya, H. I. et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12, 786-795 (2011).
54. Tsang, J. S. et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 157, 499-513 (2014).
55. Mitchell, L. A., Henderson, A. J. & Dow, S. W. Suppression of vaccine immunity by inflammatory monocytes. J. Immunol. 189, 5612-5621 (2012).
56. Kool, M. et al. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181, 3755-3759 (2008).
57. Kool, M. et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205, 869-882 (2008).
58. Huang, Q. et al. The plasticity of dendritic cell responses to pathogens and their components. Science 294, 870-875 (2001).
59. Bushel, P. pvca: Principal Variance Component Analysis (PVCA). Package version 1.0.0. (2012).